FDA Import Refusal SCS-1792059-8/11/1 — IPCA LABS LTD
The FDA refused shipment SCS-1792059-8/11/1 from IPCA LABS LTD (India) on Sep 16, 2020. The refused product falls under Drugs and Biologics — HYDROXYCHLOROQUINE SULFATE (ANTI-PROTOZOAL, A-LEISHMANIAL, A-MALARIAL). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Sep 16, 2020
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 62LCA29 HYDROXYCHLOROQUINE SULFATE (ANTI-PROTOZOAL, A-LEISHMANIAL, A-MALARIAL)
- Charges
- 75